Robert Brarens, DPM
Foot & Ankle Surgery · Cincinnati, OHNPI 1366492001
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $84,094 of the $107,531 with a category attached, or 78.2%. Stryker accounts for 93.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $32,290 and has fallen 88.3% since, to $3,792 in 2025. Among foot & ankle surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 316 payments — averaging $340.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$100K
- Legacy Ortho LLC$4K
- Smith+Nephew$1K
- Amgen$391
- In2bones USA, LLC$290
- Imperative Care, Inc$290
- plus $1K from 13 others
Across 10 payments — averaging $1073.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$11K
What the payments were for
- Consulting fees$84,09478%
- Travel & lodging$5,2815%
- Food & beverage$14,55714%
- Education$3,6003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 264 | $100,036 |
| Legacy Ortho LLC | 6 | $3,755 |
| Smith+Nephew | 19 | $1,306 |
| Amgen(2 entities) | 4 | $391 |
| In2bones USA, LLC | 3 | $290 |
| Imperative Care, Inc | 2 | $290 |
| Zimmer Biomet | 2 | $233 |
| Bioventus LLC | 3 | $207 |
| Paragon 28, Inc. | 3 | $144 |
| Cardiovascular Systems Inc. | 1 | $141 |
| Truvic Medical, Inc. | 1 | $133 |
| Flower Orthopedics Coporation | 1 | $128 |
| Heron Therapeutics, Inc. | 1 | $128 |
| Bone Support Inc. | 1 | $120 |
| Orthofix Medical, Inc. | 1 | $85 |
| Organogenesis Inc. | 1 | $56 |
| Sanara Medtech Inc. | 1 | $51 |
| Arteriocyte Medical Systems, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VARIAX$18,121
- ANCHORAGE$17,623
- 7 X 23MM CITRELOCK IMPLANT$16,276
- CITREFIX$15,428
- Viaflow$11,985
- HOFFMANN$11,122
- STAR$9,466
- ASNIS$8,227
- T2$7,030
- Actishield$5,735
- PHALINX$2,220
- ORTHOLOC 3DI$1,593
- PRIME SERIES$1,193
- Stravix$1,080
- SUBFIX$925
- SALVATION$843
- AUGMENT INJECTABLE$757
- FIXOS$666
- GRAFIX PL$547
- ORTHOLOC 2 LAPIFUSE$382
How this compares
$107,531 in reported general payments places this provider in the 95th percentile of 429 foot & ankle surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 36 | $22,143 |
| Gabapentin | 113 | $2,234 |
| Pregabalin | 51 | $2,150 |
| Duloxetine Hcl | 52 | $1,200 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $206 |
| Allopurinol | 31 | $150 |
| Promethazine Hcl | 19 | $118 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $99 |
| Meloxicam | 56 | $82 |
| Terbinafine Hcl | 12 | $63 |
| Zolpidem Tartrate | 25 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $14 | $22,14336 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 429 foot & ankle surgery providers in Ohio.
Other foot & ankle surgery in Cincinnati
- Timothy WylieCincinnati$22K
- Casie BlantonCincinnati$17K
- Christopher HyerWorthington$4.7M
- Thomas LeePickerington$4M
- Jordan GrossmanAkron$2.5M
- Robert GorslineHilliard$1.4M
- Jonathan FeibelGahanna$1.4M
- Mark PrisselWorthington$1.2M
- Lee HladGahanna$440K
- Windy ColeKent$431K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.